Point of Care Diagnostics Market Report-Key Players, Market Size, Risk Analysis, Trends, Y-O-Y Growth Analysis- By Technology(Lateral Flow, Agglutination Assays, Flow Through, Solid Phase, Biosensors), By Application(CardioMetabolic Testing, Infectious Disease Testing etc) By End User

Point of Care Diagnostics Market in the Global Industry Landscape

Point of care diagnostics (POCD) is a rapid detection of analytes nearby the patient. This facilitates the disease diagnosis, management and monitoring. POCD enables diagnosis of disease at an early stage thus helps in taking quick medical decisions, and leading to improved health of the patients. POCD market is expected to grow at a CAGR of 9.3% over the forecast period (2017-2025). North America has largest market for POCD on the back of huge healthcare expenditure in the region followed by Europe. Moreover, the Asia Pacific region is witnessed to have increasing healthcare expenditure by the country’s government and also the penetration of top healthcare companies in the region. Over the forecast period, APAC is expected to grow at fastest CAGR of 14.0%.

Further, biosensors are the most important component of POCD, which thus impacts the bioanalytical performance of an assay. Complementary technologies such as lab-on-a-chip technologies, microfluidics, device automation, system integration, and signal readout are further driving the continuous improvements in POCD. Furthermore, the POCD is surprisingly beneficial in the regions that lack healthcare facilities and bulky diagnosis devices is not feasible to deploy in the region. Thus potential benefits of POCD are short turnaround time (TAT), portability, low cost, minimal manual input, immediate clinical decision-making, and ease of use formats such that the devices can be successfully deployed at the remote settings and primary care level with poor or no laboratory infrastructure.

Our Global Point of Care Diagnostics Market can be segmented on the following basis:

Based on Technology

• Lateral Flow
• Agglutination Assays
• Flow Through
• Solid Phase
• Biosensors

Based on Application

• Cardio Metabolic Testing
• Infectious Disease Testing
• Nephrology Testing
• Drugs of Abuse (DoA) Testing
• Blood Glucose Testing
• Pregnancy Testing
• Cancer Biomarker Testing

Based on End User

• Hospitals/Critical Care centres
• Diagnostics Labs
• Households
• Research Laboratories

Market Assessment by Major Geographies:-

• North America (U.S. & Canada) Point of Care Diagnostics Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico, Argentina & Rest of Latin America) POCD Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Point of Care Diagnostics Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) POCD Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Point of Care Diagnostics Market {Market Share (%), Market Size (USD Billion)}

Global Point of Care Diagnostics Market Outlook comprises of the following data:

• Point of care diagnostics market size and market compounded annual growth rate, 2017-2025
• Point of care diagnostics deployment by region, 2017-2025
• Number of new entrants in point of care diagnostics market, 2017-2025
• Number of new cases diagnosed of chronic diseases annually, 2017-2018

In 2016 on the basis of technology, lateral flow segment accounted for largest market share in 2017 on the back of increasing cases of infectious diseases which augments the adoption of POCD instead of lab tests.

Both the communicable and non-communicable diseases, such as cardiovascular, diabetes, obesity, and cancer, among others in developing countries are increasing at a higher growth rate as compared to the developed countries. Annually in the developing world, acute respiratory infections has resulted in approximately 4.3 million deaths, where about 5 million from AIDS and tuberculosis and nearly 1 million people die due to malaria.

Expert Analysis: Rapid, accurate and inexpensive diagnosis has been the only goal of medicine. The factors such as advancement in molecular biology, improved sensitivity of assays and the miniaturization of the devices, have uplifted the point of care diagnostics market. POCD covers significant part of in vitro diagnostics, majorly for the pregnancy and diabetes testing. But huge flow of investments is witnessed in the POCD market to improve and increase the infrastructure and to deploy new products in the market.

Key Questions Answered In This Point of Care Diagnostics Market Report

• What is the total market size by 2025 and what would be the expected growth rate of the market?
• What is the revenue of POCD Market in 2015-16 and what would be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry-level players?
• What are the recent developments and business strategy of the key players?